Tumor Regression and Allograft Rejection after Administration of Anti-PD-1. (Record no. 25814281)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01554 a2200433 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517083909.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201603s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1533-4406 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1056/NEJMc1509268 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Lipson, Evan J |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20160315 |
245 00 - TITLE STATEMENT | |
Title | Tumor Regression and Allograft Rejection after Administration of Anti-PD-1. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The New England journal of medicine |
Date of publication, distribution, etc. | Mar 2016 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 896-8 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Case Reports; Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Allografts |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Squamous Cell |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Graft Rejection |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunocompromised Host |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kidney |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kidney Transplantation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Programmed Cell Death 1 Receptor |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Skin Neoplasms |
General subdivision | drug therapy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bagnasco, Serena M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Moore, Jack |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jang, Sekwon |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Patel, Manisha J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zachary, Andrea A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pardoll, Drew M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Taube, Janis M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Drake, Charles G |
773 0# - HOST ITEM ENTRY | |
Title | The New England journal of medicine |
Related parts | vol. 374 |
-- | no. 9 |
-- | p. 896-8 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1056/NEJMc1509268">https://doi.org/10.1056/NEJMc1509268</a> |
Public note | Available from publisher's website |
No items available.